Licence Changes & Product Updates

NICE recommends further migraine prevention option

NICE recommends further migraine prevention option

Galcanezumab (Emgality) is the second calcitonin gene-related...

Diabetes drug approved to treat heart failure

Diabetes drug approved to treat heart failure

Forxiga (dapagliflozin) is the first SGLT2 inhibitor...

New tablet treatment for eczema

New tablet treatment for eczema

Prescribers have a new oral treatment option for patients...

New warnings and restrictions for stimulant laxatives

New warnings and restrictions for stimulant laxatives

The MHRA has issued new safety warnings, revised recommended...

First SGLT2 inhibitor approved to treat diabetic kidney disease

First SGLT2 inhibitor approved to treat diabetic kidney disease

Canagliflozin (Invokana) can now be prescribed to slow...

New contraindication for co-cyprindiol

New contraindication for co-cyprindiol

Cyproterone-containing medicines are now contraindicated...

Uterine fibroid drug suspended over liver injury concerns

Uterine fibroid drug suspended over liver injury concerns

Healthcare professionals have been asked to stop prescribing...

Beta blocker overdose warning

Beta blocker overdose warning

The toxicity of a commonly prescribed beta blocker...

Three Insuman insulin presentations to be discontinued

Three Insuman insulin presentations to be discontinued

The Insuman range is being rationalised owing to manufacturing...

Actinic keratosis treatment recalled due to growing skin cancer concerns

Actinic keratosis treatment recalled due to growing skin cancer concerns

Healthcare professionals have been advised to stop...